护理研究
護理研究
호리연구
Chinese Nursing Research
2015年
29期
3613-3616
,共4页
贾秀芬%王君俏%杨雅%陆敏敏
賈秀芬%王君俏%楊雅%陸敏敏
가수분%왕군초%양아%륙민민
慢性阻塞性肺疾病%西雅图慢性阻塞性肺疾病问卷%信度%效度
慢性阻塞性肺疾病%西雅圖慢性阻塞性肺疾病問捲%信度%效度
만성조새성폐질병%서아도만성조새성폐질병문권%신도%효도
chronic obstructive pulmonary disease (COPD)%Seattle Obstructive Lung Disease Questionnaire (SOLQ)%reliability%validity
[目的]探讨西雅图慢性阻塞性肺疾病问卷(SOLQ)对社区慢性阻塞性肺疾病(COPD)病人生活质量评估的价值。[方法]采用SOLQ 和 COPD 评估测试工具(CAT)对102例社区 COPD 病人进行调查,验证 SOLQ 的应用价值。[结果]SOLQ 的重测信度系数为0.854(P <0.01),Cronbach’s α系数为0.961,4个维度与总量表间的结构效度为0.361~0.891(均 P <0.01),与 CAT 量表间的校标关联效度为-0.648;且各维度的高、低分组得分差异有统计学意义(均 P <0.01)。[结论]SOLQ 有良好的信度和效度,能够较好地反映社区 COPD 病人病情和生活质量。
[目的]探討西雅圖慢性阻塞性肺疾病問捲(SOLQ)對社區慢性阻塞性肺疾病(COPD)病人生活質量評估的價值。[方法]採用SOLQ 和 COPD 評估測試工具(CAT)對102例社區 COPD 病人進行調查,驗證 SOLQ 的應用價值。[結果]SOLQ 的重測信度繫數為0.854(P <0.01),Cronbach’s α繫數為0.961,4箇維度與總量錶間的結構效度為0.361~0.891(均 P <0.01),與 CAT 量錶間的校標關聯效度為-0.648;且各維度的高、低分組得分差異有統計學意義(均 P <0.01)。[結論]SOLQ 有良好的信度和效度,能夠較好地反映社區 COPD 病人病情和生活質量。
[목적]탐토서아도만성조새성폐질병문권(SOLQ)대사구만성조새성폐질병(COPD)병인생활질량평고적개치。[방법]채용SOLQ 화 COPD 평고측시공구(CAT)대102례사구 COPD 병인진행조사,험증 SOLQ 적응용개치。[결과]SOLQ 적중측신도계수위0.854(P <0.01),Cronbach’s α계수위0.961,4개유도여총량표간적결구효도위0.361~0.891(균 P <0.01),여 CAT 량표간적교표관련효도위-0.648;차각유도적고、저분조득분차이유통계학의의(균 P <0.01)。[결론]SOLQ 유량호적신도화효도,능구교호지반영사구 COPD 병인병정화생활질량。
Objective:To probe into the value of Seattle Obstructive Lung Disease Questionnaire(SOLQ)for measuring the quality of life of patients with COPD in community.Methods:A total of 102 with community COPD patients were investigated by using SOLQ and COPD assessment test(CAT)to verify the application value of SOLQ.Results:The test retest reliability coefficient of SOLQ was 0.854(P <0.01),the Cronbach’s αcoefficient was 0.961,the structural validity between the total surface and its 4 dimensions was 0.361 ~0.891 (all P <0.01),the criterion related validity between SOLQ and CAT was 0.648;there was significant differ-ence between the high and the low score group(P <0.01).Conclusion:The SOLQ had higher reliability and va-lidity,and it could well reflect the condition of disease and the quality of life of patients with community COPD.